GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹12 Cr | ₹28 Cr | ₹56 Cr | ₹60 Cr | ₹1,469 Cr |
What is the latest Short Term Loans and Advances ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Short Term Loans and Advances |
---|---|
Mar2023 | ₹12 Cr |
Mar2022 | ₹28 Cr |
Mar2021 | ₹56 Cr |
Mar2020 | ₹60 Cr |
Mar2019 | ₹1,469 Cr |
How is Short Term Loans and Advances of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2023 | ₹12 Cr | -56.97 | |
Mar2022 | ₹28 Cr | -49.73 | |
Mar2021 | ₹56 Cr | -6.28 | |
Mar2020 | ₹60 Cr | -95.90 | |
Mar2019 | ₹1,469 Cr | - |
Compare Short Term Loans and Advances of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,918.0 Cr | 8% | 27.4% | 84.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹358,689.0 Cr | -2.4% | 0.8% | 66.3% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 6.4% | 10.5% | 61.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5.1% | 9% | 31.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹109,222.0 Cr | 3.2% | 13.1% | 117.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 1.6% | -1% | 33.8% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 8% |
27.4% |
84.5% |
SENSEX | 2.4% |
2.4% |
22.8% |
You may also like the below Video Courses